Ownership history in BARCLAYS PLC · 84 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in AMICUS THERAPEUTICS, INC. USD COM (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,134,639 | +1,020,639 | +895.3% | 0.00% | $16.2M | $14.24 |
| 2025 Q3 | REDUCED | 114,000 | -855,522 | -88.2% | 0.00% | $898K | $7.88 |
| 2025 Q3 | REDUCED | 969,522 | -213,213 | -18.0% | 0.00% | $7.6M | $7.88 |
| 2025 Q2 | ADDED | 1,182,735 | +1,036,335 | +707.9% | 0.00% | $6.8M | $5.73 |
As of 2025 Q4 — sorted by position size